Black Diamond Therapeutics, Inc.
BDTX
$2.02
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -394.72% | -948.77% | 132.10% | 129.41% | 117.93% |
| Total Depreciation and Amortization | -39.83% | -22.97% | -5.25% | 0.00% | -7.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 102.94% | 50.58% | 60.98% | -15.18% | -32.59% |
| Change in Net Operating Assets | -29.38% | -92.79% | -224.22% | -517.57% | -641.15% |
| Cash from Operations | -283.72% | -376.52% | 147.53% | 134.88% | 126.19% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -94.94% | -86.92% | -71.28% | -62.79% | 107.89% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 206.51% | -186.78% | -366.28% | -1,148.38% | 46.36% |
| Cash from Investing | 206.94% | -186.50% | -364.65% | -1,083.91% | 46.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.67% | -99.38% | -99.36% | -98.21% | -99.67% |
| Repurchase of Common Stock | -3.53% | -97.22% | -23.81% | 61.07% | -700.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33.33% | -101.69% | -100.57% | -98.65% | -100.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -283.17% | -193.62% | 21.99% | 121.54% | 70.30% |